A hereditary blood disease
Thalassemia (also called Mediterranean anemia) is a hereditary blood disease,
that affects most commonly people of Mediterranean or Asian ancestry. Although
thalassemia in its severe form (thalassemia major) can lead to severe symptoms
that require lifelong treatment, patients affected by mild thalassemia
(thalassemia minor) can live normal lives without treatment, and even become
sport champions.
This is well shown by Pete Sampras, the U.S. tennis player of Greek origin who,
in spite of his disease, was able to win a record of 14 Grand Slam men's singles
titles during his 15-year tennis career.
Thalassemia is a blood disease characterized by a total or partial deficiency of
haemoglobin, the blood protein found in the red cells that is responsible for
transporting oxygen to the various tissues. This condition can lead to anemia
and associated symptoms of fatigue, weakness, short breathing, paleness or
jaundice (a yellowish colour of the skin or eyes), slow growth, facial bone
deformities and dark urine. However these symptoms are usually present in
patients affected by the severe form of thalassemia, while those affected by the
mild form (such as Pete Sampras) often suffer no symptoms or experience only
mild ones.
The cause of thalassemia has been well established and relies upon a genetic
defect in the synthesis of haemoglobin. Several genes (inherited from both
parents) are involved in the synthesis of haemoglobin, so the severity of
thalassemia depends upon how many of these genes are defective.
Severity of symptoms
In general terms we can say that the greater is the number of defective genes,
the more severe are the symptoms (such as fatigue, weakness, pale or yellowish
skin) and complications (such as bone deformities, slow growth, spleen
enlargement and heart problems).
The treatment of thalassemia depends on the severity of the disease. People who
are affected by the mild form can live normal lives even without treatment,
although they can occasionally require blood transfusions, especially after
surgery, giving birth or when they develop an infection.
On the contrary, moderate or severe thalassemia usually requires frequent blood
transfusions, which are not devoid of risk.
In fact, besides the risk of developing blood-borne infections, patients treated
with repeated blood transfusions can develop a medical condition known as iron
overload (due to excess iron), which in turn can lead to heart and liver
problems.
This is the reason why patients who receive repeated blood transfusions are
often treated also with specific medications intended to prevent iron overload.
For patients with extremely severe thalassemia, a bone marrow transplant may be
needed, although this surgical procedure is rarely performed due to its risk.
Thalassemia and remedies
Lifestyle remedies are important as well. Diet should be well balanced, rich in
nutritious energy-dense foods and possibly supplemented (according to the
doctor's advice) with folic acid to help make new red cells, as well as zinc,
calcium and vitamin D to help bones stay healthy.
However, it is important to remember that, to avoid iron overload, vitamins and
other supplements should not contain iron.
Because of their need to receive occasional or repeated transfusions, patients
affected by thalassemia should have themselves be covered by an appropriate
health insurance plans before the condition occurs.
International Health Cover is an International Health Insurance
advisor. We provide full advice over a full range of
International Medical Insurance
plans. Our quotation and advice are free.
Please request a
free
quote. You may also
contact one of our highly trained advisor.
*Always seek professional medical advise from a qualified doctor before
undergoing any treatment.
|